Learn About Medicare Coverage for Breztri

What Breztri Is and How It Works

Breztri is a prescription medication used to treat chronic obstructive pulmonary disease, commonly known as COPD. The drug's full name is beclomethasone/formoterol/glycopyrrolate, which represents three active ingredients working together in one inhaler. Understanding what this medication does can help you navigate discussions with your doctor and insurance coverage questions.

Breztri is a combination inhaler that delivers medication directly to the lungs. Each of its three components serves a different purpose. Beclomethasone is a corticosteroid that reduces inflammation in the airways. Formoterol is a long-acting beta-2 agonist that relaxes airway muscles and improves airflow. Glycopyrrolate is an anticholinergic medication that also helps open airways by blocking certain nerve signals. Together, these three medications work to reduce symptoms like shortness of breath, wheezing, and coughing in people with moderate to very severe COPD.

The medication comes in a metered-dose inhaler, which means it delivers a precise amount of medication with each use. Patients typically use Breztri twice daily, in the morning and evening. The combination approach is designed to provide more comprehensive symptom control than single-ingredient inhalers, potentially reducing the need for multiple separate medications.

Breztri received FDA approval in 2018 and has become an option for many people managing COPD. According to clinical trials, patients using Breztri showed improvements in lung function measurements and reported fewer symptoms compared to patients using other treatment approaches. The medication is not intended for acute asthma attacks or sudden breathing problems; those situations require separate rescue inhalers.

Practical takeaway: Breztri is a three-in-one maintenance inhaler for COPD that works by reducing inflammation and opening airways. Knowing how it works helps you understand why your doctor might recommend it and what questions to ask about coverage.

How Medicare Parts Work and Drug Coverage Basics

Medicare is the federal health insurance program for people age 65 and older, certain younger people with disabilities, and people with end-stage renal disease. To understand how Breztri coverage works, you need to know the basic structure of Medicare and how prescription drugs fit into each part.

Medicare has four main parts. Part A covers hospital stays, skilled nursing facility care, hospice, and some home health services. Part B covers doctors' visits, outpatient care, and some preventive services. Part D specifically covers prescription medications filled at pharmacies. Part C, also called Medicare Advantage, is an alternative to Original Medicare (Parts A and B) offered by private insurance companies that must cover at least what Original Medicare covers.

Prescription drug coverage under Part D works through formularies, which are lists of medications that a specific insurance plan covers. Each Part D plan maintains its own formulary, and these lists can vary significantly. A medication like Breztri might be covered by one plan but require special approval from another, or might have different out-of-pocket costs depending on which plan you're enrolled in.

When evaluating Part D coverage for Breztri, it's important to understand several cost-sharing terms. The deductible is the amount you pay out of pocket before your plan starts paying. The copayment (or copay) is a fixed amount you pay per prescription. Coinsurance is a percentage of the drug's cost that you pay. The donut hole, or coverage gap, is a phase where you pay a larger share of drug costs after you and your plan have spent a certain amount together in a year. In 2024, this gap begins after $5,850 in total drug costs and continues until out-of-pocket spending reaches $7,550.

Practical takeaway: Part D is your prescription drug coverage under Medicare, and each plan has different lists of covered medications with varying costs. Understanding your plan's formulary and cost structure directly affects how much you'll pay for Breztri.

Medicare Part D Formulary Status and Coverage Tiers

The first step in learning about Medicare coverage for Breztri is checking whether your specific Part D plan includes it on the plan's formulary. Not all Part D plans cover Breztri in the same way, and some may not cover it at all. The formulary status determines both whether the medication is available to you and what your costs will be.

Medications on Part D formularies are typically placed into tiers that reflect increasing cost-sharing requirements. Tier 1 includes generic drugs with the lowest copayments or coinsurance. Tier 2 includes preferred brand-name drugs, which cost more than generics but less than non-preferred options. Tier 3 includes non-preferred brand-name drugs with higher cost-sharing. Tier 4 includes specialty medications that are typically the most expensive. Tier 5 is sometimes available for additional specialty drugs. Breztri, being a brand-name combination inhaler with no generic equivalent currently available, is typically placed in Tier 3 or Tier 4 on most formularies.

The tier placement affects your out-of-pocket costs significantly. If Breztri is in Tier 3, you might pay 25-30% coinsurance. If it's in Tier 4, coinsurance might be 30-33% or higher. Some plans use flat copayments for tiers rather than percentages; these might range from $50 to $150 or more per month depending on the tier. Over a full year, these differences compound substantially. A Tier 4 placement with $100 monthly copayments means $1,200 annually just for the copayment, not including any deductible or coinsurance after the coverage gap.

To find your plan's specific formulary status for Breztri, you can visit Medicare.gov and use the plan finder tool, or contact your Part D plan directly. When you check, ask specifically about prior authorization requirements. Prior authorization means your doctor must get approval from the insurance company before the pharmacy can fill the prescription. Some plans require prior authorization for Breztri to confirm that you've tried certain other medications first. Understanding these requirements in advance prevents delays in getting your medication filled.

Practical takeaway: Check your specific Part D plan's formulary to learn what tier Breztri is on, which determines your copayment or coinsurance amount. Contact your plan or use Medicare.gov to get this information before you need the medication.

Prior Authorization and Step Therapy Requirements

Many Medicare Part D plans require prior authorization before covering Breztri, meaning your doctor must submit a request to the insurance plan explaining why Breztri is medically necessary for you. This process can delay when you receive your medication, sometimes by several days, so understanding how it works helps you plan ahead with your healthcare provider.

Prior authorization exists to help manage medication costs and encourage appropriate prescribing. Insurance plans want to confirm that less expensive alternatives haven't worked adequately for your specific situation before covering higher-cost medications like Breztri. The plan's medical team reviews your request and may approve it, deny it, or approve it with conditions.

Related to prior authorization is a practice called step therapy, also called fail-first protocols. With step therapy, your insurance plan may require that you try and document that you've tried one or more alternative medications before it will cover Breztri. For example, your plan might require that you've tried a less expensive two-ingredient COPD inhaler or tried certain other single-ingredient medications without achieving adequate symptom control. Only after these documented attempts would the plan cover Breztri.

Step therapy is based on the idea that many people respond well to less expensive medications and that trying those first saves money for the insurance plan. However, your doctor may believe step therapy is medically inappropriate for your particular situation—for example, if you've previously used those other medications with poor results, or if your lung function is too compromised to wait. In these cases, your doctor can request an exception to the step therapy requirement through what's sometimes called a formulary exception request.

The process typically works this way: your doctor submits the prior authorization request with your medical history. The insurance plan reviews it, usually within a few days. They either approve Breztri, request that you try a step therapy medication first, or deny coverage. If denied, you and your doctor have the right to appeal. The appeal process can take additional time, sometimes 15-30 days, which is why discussing this with your